Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05439265 · ClinicalTrials.gov registry record
EMR Tool Impact on HIT Documentation and Management
A clinical trial, sponsored by Rush University Medical Center.
- Completed
- Registry status
- 128
- Enrollment target
NCT05439265: Completed study, sponsored by Rush University Medical Center.
NCT05439265 is a clinical trial that has completed, run by Rush University Medical Center. The registered enrollment target is 128 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05439265 has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- 128 participants
- Enrollment target
Study Summary
Heparin-induced thrombocytopenia (HIT) is an immune-mediated adverse drug reaction to heparin products which results in a prothrombotic state. Heparin-induced thrombocytopenia generally occurs several days after the start of unfractionated heparin or low molecular weight heparin and is diagnosed based on clinical presentation, and presence of thrombocytopenia. HIT has an incidence of 0.1% to 5% and if recognized early can help prevent major complications. As of November 2014, the responsibility for documenting heparin allergies in the electronic medical record (EMR) has shifted from the physician/medical resident to the pharmacy resident. The purpose of this study is to compare the number, rate, and appropriateness of heparin allergy documentation in order to help decrease adverse medical events related to heparin.
Primary Outcome
1\. Completion of appropriate allergy documentation will include all of the following: a. Heparin allergy documented i. Pending result ii. Positive result b. Heparin allergy removed i. Negative result
Interventions
- OTHER Electronic medical record order panel and resident involvement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2014-01 |
| Est. Completion | 2017-04 |
What the finished NCT05439265 record still lists
NCT05439265 is an observational study that tracks outcomes without assigning an intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Electronic medical record order panel and resident involvement is the first listed.
NCT05439265 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05439265 about?
NCT05439265 is a clinical study titled "EMR Tool Impact on HIT Documentation and Management". Heparin-induced thrombocytopenia (HIT) is an immune-mediated adverse drug reaction to heparin products which results in a prothrombotic state. Heparin-induced thrombocytopenia generally occurs several days after the start of unfractionated heparin or low molecular weight heparin and is diagnosed bas...
What is the current status of trial NCT05439265?
This trial is currently completed. The enrollment target is 128 participants. The study started on 2014-01. Estimated completion is 2017-04.
What interventions are being tested in trial NCT05439265?
The interventions under investigation include: Electronic medical record order panel and resident involvement (OTHER).
Who is sponsoring clinical trial NCT05439265?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02870738 · 128 participants · Phase 2
Bladder Directed vs. Pelvic Floor Therapy in IC/BPS
- NCT03294460 · 128 participants · Phase 1
Nicotinic Receptor Genetic Variation and Alcohol Reward
- NCT04149977 · 128 participants · NA
Blood Flow Restriction Therapy in Lower Limb Extensor Injuries
- NCT04373057 · 128 participants · Phase 1
Prebiotic Galacto-oligosaccharide and Acute GVHD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia